Genome therapy is a part of precision medicine that is slowly going mainstream as policy clarifies reimbursement. The National Institutes of Health, for instance, is working on removing barriers that slow the adoption of genome editing for treating patients.
NIH announced this week the launch of Somatic Cell Genome Editing, a program aimed at picking up the pace in which the technology moves to the clinic for treatment. more